Kofituss Sedativo Tossetosse

Levodropropizine, the active ingredient in Kofituss Sedativo Tossetosse, is an antitussive presented as an oral formulation for oral use. It is indicated for the symptomatic treatment of dry, non‑productive coughs in both adult and pediatric populations, offering cough relief without central nervous system effects.

GNH USA supplies Kofituss Sedativo Tossetosse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑registered manufacturers to ensure quality and regulatory compliance.

Levodropropizine is an antitussive that acts on peripheral sensory nerves to suppress cough.

- Dry cough: reduces the frequency and intensity of coughing episodes. - Non‑productive cough: alleviates irritation‑driven cough without producing sputum. - Cough associated with upper respiratory tract irritation: provides symptomatic relief by dampening the cough reflex.

Levodropropizine may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Dyspepsia: indigestion or discomfort. - Headache: transient mild headache. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Hepatotoxicity: signs of liver dysfunction. - Blood dyscrasias: rare blood count abnormalities. - Severe skin reactions: Stevens‑Johnson syndrome.

When prescribing Levodropropizine, consider the following precautions.

- Use in children: follow prescriber guidance, dosage based on age and weight. - Renal impairment: consider dose adjustment if renal function is reduced. - Hepatic impairment: monitor liver function, adjust if necessary. - Concomitant CNS depressants: no significant interaction, but monitor for additive sedation. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Levodropropizine has a limited interaction profile, but certain combinations require attention.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive reactions. - Anticholinergic drugs: potential additive anticholinergic effects.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedative sensations. - NSAIDs: monitor for gastrointestinal irritation. - Other cough suppressants: risk of additive cough suppression. - Alcohol: may increase dizziness or gastrointestinal upset.